ReviewiScience2025
Unlocking private finance for nature: Addressing barriers and reframing risk-return dynamics.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A framework for unit-level biodiversity credit integrity and market-level governance.npj biodiversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Public finance alone is insufficient to meet the scale of investment required for nature protection, restoration, and sustainable management. Mobilizing private capital is therefore essential, yet most nature-related projects are perceived as unbankable. They sit at the frontier of bankability: nascent and unproven initiatives that lack historical track records, face high execution risks, and generate uncertain or delayed revenues. This misalignment is compounded by investor behavior, as most financiers demand commercial rates of return, standardized transactions, and short payback periods. Even though investors differ in their appetite for risk, nature projects rarely meet these thresholds. Through a systematic review of literature across five ecosystems and three intervention types, this review identifies persistent barriers: limited financial returns, high risk, high transaction costs, and undervaluation of nature. We note that enabling conditions such as blended finance, risk-sharing instruments, and supportive regulation exist; however, we argue that reframing risk-return dynamics is critical to unlock scalable private finance for nature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.